Labviva News Roundup

Here's the latest Labviva news:

Here's the latest Labviva news:
Healthcare Procurement Takes The Vantage Point Of The Scientist - an interview with Labviva CEO Siamak Baharloo
“Scientific research is complex, manufacturing biologics is complex, testing is complex, so they need to always have access to a larger number of suppliers and manufacturers.”
Read the rest on PYMNTS:

Labviva Announces US$8mn Series Seed Capital Raise

“Given that the company’s approach helps to improve the relationship between suppliers and manufacturers of life sciences products and enterprise purchases, you can probably expect to see more successful funding rounds in the future.”

Read the rest in Procurement Magazine:
Boston Business Journal:

Labviva Inc.: $8 million. Labviva, a Cambridge-based platform that connects researchers with suppliers of reagents, chemicals and instrumentation, raised $8 million in equity from three investors, according to a Form D filed on June 15. CEO Siamak Baharloo, who completed his training as a geneticist at the University of California San Francisco, co-founded the company in 2017.
See the entire article:

Similar posts

Want to stay on top of what's happening at Labviva?

Sign up to receive updates the lastest in AI, life sciences, and procurement.